Mary E. Paetzold

Mary E. Paetzold discloses dealings in Immunomedics Inc to SEC (Form 4). Between 3 December 2008 and 2 December 2016, the trades on record add up to 20 filings.

Sales make up the whole of the open-market record (3 sales, €96k). Outside the open market, there are 4 share grants and 13 option exercises. In 2016 alone, the filings show no purchases and 1 sale.

The latest filing, published on 7 December 2016, reports an option exercise in Immunomedics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.